- Home
- KLAC vs PFE Comparison
KLAC vs PFE Comparison
Compare KLAC & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLAC
- PFE
- Stock Information
- Founded
- KLAC 1975
- PFE 1849
- Country
- KLAC United States
- PFE United States
- Employees
- KLAC N/A
- PFE N/A
- Industry
- KLAC Electronic Components
- PFE Biotechnology: Pharmaceutical Preparations
- Sector
- KLAC Technology
- PFE Health Care
- Exchange
- KLAC Nasdaq
- PFE Nasdaq
- Market Cap
- KLAC 122.3B
- PFE 134.2B
- IPO Year
- KLAC N/A
- PFE N/A
- Fundamental
- Price
- KLAC $914.80
- PFE $24.58
- Analyst Decision
- KLAC Buy
- PFE Hold
- Analyst Count
- KLAC 20
- PFE 13
- Target Price
- KLAC $882.10
- PFE $29.75
- AVG Volume (30 Days)
- KLAC 1.0M
- PFE 46.0M
- Earning Date
- KLAC 07-31-2025
- PFE 08-05-2025
- Dividend Yield
- KLAC 0.83%
- PFE 7.00%
- EPS Growth
- KLAC 49.75
- PFE N/A
- EPS
- KLAC 30.37
- PFE 1.89
- Revenue
- KLAC $12,156,162,000.00
- PFE $63,833,000,000.00
- Revenue This Year
- KLAC $4.21
- PFE N/A
- Revenue Next Year
- KLAC $9.49
- PFE N/A
- P/E Ratio
- KLAC $30.12
- PFE $12.98
- Revenue Growth
- KLAC 23.89
- PFE 13.53
- 52 Week Low
- KLAC $551.33
- PFE $20.92
- 52 Week High
- KLAC $945.87
- PFE $30.43
- Technical
- Relative Strength Index (RSI)
- KLAC 53.85
- PFE 52.04
- Support Level
- KLAC $869.22
- PFE $23.86
- Resistance Level
- KLAC $921.99
- PFE $24.89
- Average True Range (ATR)
- KLAC 25.05
- PFE 0.50
- MACD
- KLAC -3.31
- PFE -0.03
- Stochastic Oscillator
- KLAC 71.38
- PFE 60.49
About KLAC KLA Corporation
KLA is one of the largest semiconductor wafer fabrication equipment, or WFE, manufacturers in the world. It specializes in the market segment of semiconductor process control, wherein machines inspect semiconductor wafers during research and development and manufacturing for defects and verify precise measurements. In this section of the market, KLA holds a majority share. It also has a small exposure to the etch and deposition segments of the WFE market. It counts as top customers the largest chipmakers in the world, including TSMC and Samsung.
About PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.